NCT05293522 - A Study of NTX-001 in the Treatment and Prevention of Facial Paralysis Requiring Surgical Repair. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 12, 2022

Primary Completion Date

August 22, 2023

Study Completion Date

August 22, 2023

Conditions

Facial Paralysis

Interventions

COMBINATION_PRODUCT

NTX-001

2 solutions plus a delivery device; one time use surgical product

Trial Locations (6)

Memorial Sloan Kettering, New York

University of Indiana, Indianapolis

Rush University Medical Center, Chicago

Washington University, St Louis

Houston Methodist, Houston

Duke University Medical Center, Durham